Authors: Deborah Schrag; Harinder S. Garewal; Harold J. Burstein; David J. Samson; Daniel D. Von Hoff; Mark R. Somerfield
Working Group Members: Deborah Schrag, MD (Co-chair), Memorial Sloan-Kettering Cancer Center; Daniel D. Von Hoff, MD (Co-chair), Arizona Cancer Center; Jaffer Ajani, MD, UT M.D. Anderson Cancer Center; Al B. Benson III, MD, Northwestern University Feinberg School of Medicine; Harold J. Burstein, MD, PhD, Dana-Farber Cancer Institute; Rowan T. Chlebowski, MD, PhD, Harbor UCLA Medical Center; Harinder S. Garewal, MD, PhD, Arizona Cancer Center; Anne Hamburger, PhD, Cancer Center-University of Maryland; Axel Hanauske, MD, PhD, Sections Medical Oncology, Germany; Lawrence B. Holt Jr, MD, FACP, Coastal Cancer Center; Samir N. Khleif, MD, NCI Naval Hospital Bethesda; Gary H. Lyman, MD, University of Rochester Medical Center; Cheryl Perkins, Susan G. Komen Foundation; John Sandbach, MD, Texas Oncology Cancer Center; James A. Talcott, MD, Massachusetts General Hospital; Peter H. Wiernik, MD, OLM Cancer Center; David J. Samson (Ex-Officio), Blue Cross Blue Shield Association